ACW.AX - Actinogen Medical Limited

ASX - ASX Delayed price. Currency in AUD

Actinogen Medical Limited

109 Pitt Street
Suite 901 Level 9
Sydney, NSW 2000
61 2 8964 7401

Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Steven G. Gourlay ), FRACP, M.B.A., MBBS (M.D., Ph.D.MD, CEO & Director529.1kN/A1960
Mr. Jeff Carter BFinAdmin, MAppFinChief Financial Officer112.8kN/A1958
Ms. Tamara MillerSr. VP of Product Devel.406.56kN/AN/A
Prof. Paul Rolan D.C.P.S.A., F.F.P.M., F.R.A.C.P., M.B.B.S., M.D.Head of Clinical Pharmacology & Lead Physician and Depression164.02kN/AN/A
Mr. Michael RobertsHead of Investor Relations & Corp. CommunicationsN/AN/AN/A
Ms. Therese RussellHead of People & InfrastructureN/AN/AN/A
Dr. Christian ToouliHead of Bus. Devel.N/AN/AN/A
Dr. Dana C. Hilt M.D.Chief Medical Officer & Member of Depression and Cognition Clinical Advisory BoardN/AN/A1953
Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D., MAICDCompany Sec.N/AN/A1963
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Corporate governance

Actinogen Medical Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.